Malta vs Zimbabwe: Life science patents granted, by technology

Malta
1 patents
in 1991
Zimbabwe
1 patents
in 1995
Malta rank
54th
Zimbabwe rank
54th

Life science patents granted, by technology over time

  • Malta
  • Zimbabwe
0510152025198019871995

How they compare

Malta currently reports 1 patents against 1 patents in Zimbabwe, a difference of 0 patents.

Across all 10 years both countries report, Zimbabwe has been ahead every year.

Malta ranks 54th and Zimbabwe ranks 54th of 64 countries.

Zimbabwe has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Malta Zimbabwe Difference Ahead
1980s 2.75 patents 18.25 patents 15.5 patents Zimbabwe
1990s 2 patents 11.5 patents 9.5 patents Zimbabwe

Averages of every year both report within each decade.

Frequently asked questions

Which has higher life science patents granted, by technology, Malta or Zimbabwe?
Malta, at 1 patents against 1 patents in Zimbabwe as of 1991.
What is the difference in life science patents granted, by technology between Malta and Zimbabwe?
0 patents, with Malta ahead.
How many years of comparable data are there for Malta and Zimbabwe?
10 years are reported by both, from 1980 to 1991.
How do Malta and Zimbabwe rank globally for life science patents granted, by technology?
Malta ranks 54th and Zimbabwe ranks 54th of 64 countries.
Where does this data come from?
World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Life science patents granted, by technology
Unit
patents
Source
World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
65 places, 2,044 data points, 1980–2023
Last refreshed

Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.